Taking other pills with a semaglutide tablet: what the label studied

Before you read. This page reports what the FDA label says about specific medicines studied alongside oral semaglutide. It cannot tell you whether your own combination is safe — only a pharmacist or prescriber with your full medication list can do that. Nothing here tells you to start, stop, move or space out any medicine. If you are working out a complicated morning, a pharmacist will do it with you for free, and that is the right place to take it.

Quick answer

There are two separate questions here, and mixing them up is why this topic reads as confusing.

The timing question. The label's administration instruction names other oral medicines in the same breath as food: after taking the tablet, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications. Your morning pills are not exempt from the window.

The interaction question. Beyond timing, the studied list is short and mostly uneventful. Ten drugs were tested against semaglutide tablets. Nine showed no clinically significant difference. One did: levothyroxine, at 33% higher total exposure — with peak concentration unchanged.

The label's own guidance for anything not on that list is a single principle rather than a table: for oral drugs with a narrow therapeutic index, or that require clinical monitoring, consider increased clinical or laboratory monitoring.

Keep the tablet and the rest of the morning on one timeline →

Why other pills are in the same sentence as breakfast

Because from the tablet's point of view they are the same kind of problem.

Semaglutide tablets are absorbed in the stomach itself, through a narrow local window opened by an absorption enhancer, and only 0.4% to 1% of the dose gets through even under ideal conditions. Anything else dissolving in there at the same time is competing for that window. A blood-pressure tablet is not food, but it is matter in a stomach that needed to be empty.

That is the whole reason other oral medicines sit inside the same 30-minute fence rather than beside it. Why the tablet needs an empty stomach at all goes through the mechanism and the numbers behind it.

Note the direction of that concern: it is about protecting the semaglutide dose. The separate question — whether semaglutide changes what your other medicines do — is the next section, and it has a different answer.

The ten drugs that were actually studied

Here is the list, as the label reports it. It is shorter than people expect and more specific than most summaries make it.

Drug studied	What the label found
Levothyroxine	Total thyroxine AUC increased 33%; Cmax unchanged
Omeprazole	No clinically significant difference in semaglutide pharmacokinetics
Lisinopril	No clinically significant difference
Warfarin (S- and R-)	No clinically significant difference
Metformin	No clinically significant difference
Digoxin	No clinically significant difference
Ethinyl estradiol	No clinically significant difference
Levonorgestrel	No clinically significant difference
Furosemide	No clinically significant difference
Rosuvastatin	No clinically significant difference

The label adds one more line worth having: in vitro, semaglutide has very low potential to inhibit or induce CYP enzymes, and to inhibit drug transporters. That is the machinery behind most classic drug-drug interactions, and semaglutide barely touches it.

Which is why the studied list is short. There was no broad mechanism to chase — only the physical one, gastric emptying, and the drugs most likely to be affected by it.

The levothyroxine result, and what it does and does not say

This is the one exception, so it deserves the detail rather than a headline.

A single 600 mcg dose of levothyroxine given together with semaglutide tablets produced a 33% increase in total thyroxine AUC — total exposure over time. Maximum concentration was unchanged. The label attributes it to the mechanism it names in the same section: semaglutide delays gastric emptying, and that has the potential to affect the absorption of other oral drugs.

Three things follow, and none of them is "stop taking one of them."

More exposure, not less. The direction here is upward. Thyroid replacement is dosed to a target and monitored by blood test, which is exactly the situation the label's monitoring advice describes.

AUC moved; Cmax did not. The peak was the same; the area under the curve was larger. That is a different shape of change from a spike, and it is the kind a periodic blood test is designed to catch.

It was a single-dose study. One 600 mcg dose in a drug-interaction trial is not the same thing as daily replacement therapy in a person with a thyroid condition, and the label does not extrapolate from one to the other.

If you take levothyroxine, this belongs in a conversation with whoever manages your thyroid. It is a monitoring question, not an emergency, and they will already know the interaction exists.

A morning with three medicines in it is a sequencing problem, and sequencing is what memory is worst at. Takely records what you took and when — the tablet, the timer, and the rest — on one private timeline. Open Takely in your browser →

What about birth control?

The label studied both components of a common combined oral contraceptive — ethinyl estradiol and levonorgestrel — and reports no clinically significant differences in their pharmacokinetics when used concomitantly with semaglutide.

That is a pharmacokinetic finding about drug levels, and it is what the label says. It is not a general statement about contraceptive effectiveness in every circumstance, and it does not cover what happens if vomiting or severe diarrhoea interferes with absorption of anything swallowed — a real consideration on a drug whose most common adverse reactions are gastrointestinal.

So: the studied interaction is unremarkable, and the practical caveat sits elsewhere. Both points are worth raising with a prescriber rather than settling from a web page.

What the label says about everything else

There is no exhaustive table, and the label does not pretend there is one. What it gives instead is a rule for the unlisted:

When using RYBELSUS or OZEMPIC tablets concomitantly with other oral drugs that have a narrow therapeutic index or that require clinical monitoring, consider increased clinical or laboratory monitoring.

"Narrow therapeutic index" means the gap between an effective dose and a problematic one is small — the drugs where a 30% shift in exposure is a clinical event rather than a curiosity. Your pharmacist knows which of yours are in that category. It is precisely the question a pharmacist can answer in two minutes with your full list in front of them, and precisely the one that cannot be answered generically.

One more separate case the label handles in its own subsection: taken with an insulin secretagogue such as a sulfonylurea, or with insulin, semaglutide raises the risk of hypoglycaemia, and the label suggests considering a dose reduction of the other medicine when starting. That is a prescribing decision, listed here so you know it exists rather than so you act on it.

Fitting a morning that already has pills in it

The practical shape of this, once the pharmacology is settled.

The semaglutide tablet goes first, on an empty stomach, with up to 4 ounces of plain water. Then 30 minutes. Then everything else — breakfast, coffee, and the rest of the morning's medicines, each following its own instructions from that point.

Two pressure points come up repeatedly. A medicine that itself wants an empty stomach — levothyroxine is the common one — now has two empty-stomach requirements competing for one morning. And a time-critical medicine cannot simply be pushed back half an hour because a new tablet arrived in the routine.

Neither is something to solve by guessing which one matters more. Both are exactly what a pharmacist untangles, and doing it once produces a sequence you can then just follow. The 30-minute wait, step by step covers the mechanics of the window itself; Takely will keep the tablet, the timer and the rest of the morning on one timeline once the sequence is settled.

The other half of the question — what semaglutide does to you

Worth separating, because searches for "interactions" often mean something else entirely.

If the question is really is this symptom coming from the drug, that is not an interaction question and the answer is in the label's adverse-reaction and postmarketing sections rather than its drug-interaction one. We go through it symptom by symptom against the label, including the three most-searched symptoms that turn out not to be listed at all.

Frequently asked questions

Can I take my other medications with a semaglutide tablet?

Not at the same moment. The label's instruction names other oral medicines alongside food and drink: wait at least 30 minutes after the tablet before taking them. Beyond timing, ten drugs have been studied and nine showed no clinically significant difference.

Does Rybelsus interact with levothyroxine?

Yes, and it is the one studied exception. Total thyroxine exposure increased 33% when a single 600 mcg levothyroxine dose was given with semaglutide tablets, while peak concentration was unchanged. The label attributes it to delayed gastric emptying and advises considering increased monitoring. Raise it with whoever manages your thyroid.

Does the semaglutide tablet affect birth control?

The label reports no clinically significant difference in the pharmacokinetics of ethinyl estradiol or levonorgestrel taken with semaglutide. That is a statement about drug levels in a study, not a guarantee covering every situation — vomiting or severe diarrhoea can affect anything swallowed, and that is worth asking a prescriber about.

Does it interact with warfarin or metformin?

Neither showed a clinically significant difference in the label's interaction studies — S-warfarin, R-warfarin and metformin are all on the list of drugs whose pharmacokinetics were unchanged. Warfarin is still a narrow-therapeutic-index medicine, so normal monitoring continues to apply.

What if my medicine is not on the list?

The label gives a principle rather than a table: for oral drugs with a narrow therapeutic index, or that need clinical monitoring, consider increased clinical or laboratory monitoring. Your pharmacist can tell you in a couple of minutes which of your medicines fall into that group.

Primary sources and further reading

Labels are revised. Everything on this page was checked against the sources above on 31 August 2026. Check the current label and ask your clinician or pharmacist about your own prescription.